Avalon GloboCare Corp.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | — | $1.3M | $1.3M | $1.2M | $1.4M |
| Gross profit | — | — | — | $272,728 | $414,518 |
| Operating income | -$7.6M | -$4.8M | -$15.8M | -$8.8M | -$8.8M |
| Operating expenses | — | $1.1M | $1.0M | $929,441 | $9.2M |
| Cash from operations | -$4.6M | -$5.0M | -$6.5M | -$7.0M | -$5.0M |
| Capital expenditure | — | — | $22,159 | $1,749 | $17,502 |
| Free cash flow | — | — | -$6.5M | -$7.0M | -$5.0M |
| Impairments | — | $111,033 | $454,679 | $22,285 | — |
| Total assets | $23.4M | $21.0M | $20.6M | $19.8M | $10.2M |
| Total liabilities | $14.2M | $13.9M | $13.2M | $8.6M | $7.2M |
Shares outstanding 12.0M · Free float 78.9%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.